LP-204A1

N/A

Report date: 2025/01/26 18:18:44
NME

Base Information

Drug NameLP-204A1
Drug Alias NameLP-204A1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-1 inhibitorsCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2Cyclooxygenase-1
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLaminar Pharmaceuticals SA
China Registration ClassN/A

Develop Information

Inactive CompaniesAbility Pharmaceuticals Sl
Active IndicationsInflammation
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A